• Foundation
  • About 14 min
  • 5 practice questions

Biotechnology in medicine

Explain how human insulin is made by recombinant DNA, how gene therapy treats ADA deficiency, and how PCR and ELISA help diagnosis.

If something looks wrong, please tell us.

Some of the most important results of biotechnology are in hospitals. Medicines that once came from animals are now made by bacteria, faulty genes can sometimes be supplemented with working copies, and diseases can be found before symptoms appear. This lesson explains four such uses in plain steps.

Human insulin from bacteria

People with some forms of diabetes need insulin, a hormone that controls blood sugar. Earlier, insulin was taken from the pancreas of slaughtered cattle and pigs. It worked, but some patients developed allergies or other reactions because it was not exactly human insulin.

Insulin is made of two short chains, called A and B, joined by disulphide bridges. In the body it is first made as a longer molecule, pro-insulin, which has an extra piece called the C peptide; this piece is removed to give mature insulin. In the genetic-engineering method, DNA sequences for chain A and chain B are put into plasmids of E. coli. The bacteria make the two chains separately; the chains are extracted and joined by disulphide bonds to form human insulin.

Gene therapy

Gene therapy treats a disease caused by a faulty gene by putting a working copy of the gene into the patient's cells. The first clinical gene therapy treated adenosine deaminase (ADA) deficiency. ADA is an enzyme needed for the immune system to work; without it, the person suffers from severe immune deficiency.

In one approach, white blood cells called lymphocytes are taken from the patient and grown outside the body. A working ADA gene (as cDNA) is put into them using a retrovirus as the vector, and the cells are returned to the patient. These cells do not live for ever, so the treatment has to be repeated from time to time. If the gene is put into cells at a very early stage of development, such as bone-marrow cells that keep making new blood cells, the cure could be permanent.

Molecular diagnosis

Many infections can be found only after the germ has multiplied enough to cause symptoms. PCR (polymerase chain reaction) makes millions of copies of a tiny amount of DNA, so even a few copies of a germ's DNA can be detected early, for example in people suspected to have HIV. ELISA works on a different principle: it detects an infection through the reaction between an antigen (a molecule from the germ) and an antibody.

Worked example 1: why recombinant insulin is better

A student asks why hospitals moved from animal insulin to recombinant human insulin. Reason it out. Step 1: animal insulin is slightly different from human insulin, so some patients react to it. Step 2: recombinant insulin is made from human DNA sequences, so it has the human structure. Step 3: bacteria grow fast in bioreactors, so large amounts can be made without depending on animals. Conclusion: fewer reactions and a reliable supply.

Worked example 2: why ADA treatment is repeated

A patient treated by lymphocyte gene therapy needs repeat treatment. Step 1: the working gene was added only to mature lymphocytes. Step 2: lymphocytes have a limited life, so they die over time. Step 3: when they die, the working gene is lost with them, and the new lymphocytes the body makes still carry the faulty gene. Hence the treatment must be repeated, unless the gene is put into early, long-lived cells.

Recombinant insulin: chains A and B made separately in E. coli and joined by disulphide bonds. Gene therapy: add a working gene to correct a faulty one (first used for ADA deficiency). PCR copies DNA; ELISA uses antigen-antibody reaction.

— Rule to remember

Key takeaways

Biotechnology gives safer insulin, gene therapy for single-gene diseases and early, sensitive diagnosis. Remember the C peptide is removed from pro-insulin, the retrovirus carries the ADA gene in gene therapy, and PCR and ELISA work on different principles.

Check your understanding

  1. 1. Insulin consists of

    1. a single chain with no bridges
    2. two chains, A and B, joined by disulphide bridges
    3. three chains, A, B and C, all present in mature insulin
    4. four chains joined by ligase
    Show answer

    Answer: B. Mature insulin has chains A and B linked by disulphide bridges. The C peptide is removed from pro-insulin.

  2. 2. Why did some patients react to insulin taken from cattle and pigs?

    1. It contained live bacteria from the animals
    2. It was not exactly the same as human insulin
    3. It had no A chain, only the B chain
    4. It was made by yeast instead of animals
    Show answer

    Answer: B. Animal insulin differs slightly from human insulin, so some patients developed allergies or other reactions.

  3. 3. The first clinical gene therapy was used to treat

    1. diabetes caused by lack of insulin
    2. night blindness from vitamin A shortage
    3. the common cold caused by a virus
    4. adenosine deaminase (ADA) deficiency
    Show answer

    Answer: D. Gene therapy was first given to treat ADA deficiency, a severe immune disorder caused by a faulty ADA gene.

  4. 4. In gene therapy for ADA deficiency, the working gene is put into lymphocytes using

    1. a retrovirus as the vector
    2. DNA ligase as the vector
    3. an antibiotic as the vector
    4. chilled ethanol as the vector
    Show answer

    Answer: A. A retroviral vector carries the functional ADA cDNA into the patient's cultured lymphocytes.

  5. 5. Which technique detects a disease by making many copies of a small amount of DNA?

    1. ELISA
    2. Gel electrophoresis
    3. PCR
    4. Fermentation
    Show answer

    Answer: C. PCR (polymerase chain reaction) amplifies DNA so that even very small amounts can be detected. ELISA uses antigen-antibody reactions.

Privacy · Terms · Refunds · Delivery